文献速递前列腺癌

4Kscore作为前列腺特异性抗原反射检测在GÖTEBORG-2前列腺癌筛查试验中的性能

Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial.
PubMed 文献 · Eur Urol · 2024-05-20

在GÖTEBORG-2前列腺癌筛查试验中,对571例PSA≥3.0 ng/ml且结果可评估的男性计算4Kscore,评估预设cutoff 7.5%的性能。4Kscore识别中高危前列腺癌的AUC为0.84,阳性预测值15%、阴性预测值99%;每1000例PSA升高男性中,加入4Kscore可避免408例MRI和95例活检,减少23例低级别癌诊断,但延迟4例中级别癌诊断。

要点

  • 4Kscore识别中高危前列腺癌的AUC为0.84(95%CI 0.79-0.89)。
  • 预设cutoff 7.5%时,阳性预测值15%(0.12-0.20),阴性预测值99%(97-100)。
  • 每1000例PSA升高男性,加入4Kscore可避免408例MRI和95例活检。

核心结论

  • 将4Kscore作为PSA升高男性的反射检测可显著减少MRI和活检需求,并减少低级别前列腺癌的过度诊断,代价是延迟少数中级别前列腺癌的诊断。

研究设计与样本

  • 对571例PSA≥3.0 ng/ml且结果可评估的男性计算4Kscore,评估预设cutoff 7.5%的性能。

主要发现

  • 4Kscore识别中高危前列腺癌的AUC为0.84(95%CI 0.79-0.89)。
  • 阳性预测值为15%(0.12-0.20),阴性预测值为99%(97-100)。
  • 54例诊断为中或高级别前列腺癌的男性中,2例4Kscore低于cutoff 7.5%,均为器官局限的中危前列腺癌。
  • 每1000例PSA升高男性中,加入4Kscore可避免408例(41%)MRI、95例(减少28%)活检和23例(减少23%)低级别癌诊断,同时延迟4例(4%)中级别癌诊断。

关键数值与推荐

  • 预设4Kscore cutoff为7.5%。
  • 4Kscore识别中高危前列腺癌的AUC为0.84(95%CI 0.79-0.89)。
  • 阳性预测值15%(0.12-0.20),阴性预测值99%(97-100)。

临床怎么用

  • 作者认为这些结果为进一步将新的血液生物标志物与PSA联合纳入以改善前列腺癌筛查的获益-伤害比、减少对资源要求高的MRI和活检需求提供了证据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: We investigated whether adding 4Kscore as a reflex test to prostate-specific antigen (PSA) could improve the screening algorithm for prostate cancer (PC). METHODS: In the GÖTEBORG-2 PC screening trial, 38 000men (50-60 yr) were invited to PSA testing and, if elevated, followed by magnetic resonance imaging (MRI). For 571 men with PSA ≥3.0 ng/ml and evaluable outcomes, 4Kscore was calculated. The performance using a prespecified 4Kscore cutoff of 7.5% was evaluated. KEY FINDINGS AND LIMITATIONS: The area under the curve for 4Kscore to identify intermediate- and high-risk PC was 0.84 (95% confidence interval 0.79-0.89), and the positive predictive value, and negative predictive value were 15% (0.12-0.20) and 99% (97-100%), respectively. Of the 54 men diagnosed with intermediate- or high-grade PC, two had a 4Kscore cutoff below 7.5%, both with organ-confined intermediate-risk PC. Per 1000 men with elevated PSA, adding 4Kscore would have resulted in avoidance of MRI for 408 (41%) men, biopsies for 95 (28% reduction) men, and diagnosis of 23 low-grade cancers (23% reduction) while delaying the diagnosis of four men with intermediate-grade cancers (4%). CONCLUSIONS AND CLINICAL IMPLICATIONS: Including 4Kscore as a reflex test for men with elevated PSA reduces the need for MRI and biopsy markedly, and results in less overdiagnosis of low-grade PC at the cost of delaying the diagnosis of intermediate-grade PC in a few men. These results add further evidence for including new blood-based biomarkers in addition to PSA to improve the harm and benefit ratio of PC screening and reduce the need for resource-demanding MRI and biopsies.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Josefsson A, Månsson M, Kohestani K, et al. Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial. Eur Urol. 2024. PMID: 38772787. doi:10.1016/j.eururo.2024.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。